BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control

BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV DNA has also been found in human brain, pancreatic islet, and urinary tract tumors, implicating this virus in neoplastic processes. BKV T an...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of virology Vol. 70; no. 4; p. 2378
Main Authors:	Harris, K F, Christensen, J B, Imperiale, M J
Format:	Journal Article
Language:	English
Published:	United States 01.04.1996
Subjects:	Animals Antigens, Polyomavirus Transforming - metabolism Antigens, Polyomavirus Transforming - physiology BK Virus - immunology BK Virus - physiology Cell Division Cell Line Cell Transformation, Viral - physiology Cercopithecus aethiops Humans Nuclear Proteins - metabolism Phosphoproteins - metabolism Protein Binding Proteins Retinoblastoma Protein - metabolism Retinoblastoma-Like Protein p107 Retinoblastoma-Like Protein p130 Tumor Suppressor Protein p53 - metabolism
ISSN:	0022-538X
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV DNA has also been found in human brain, pancreatic islet, and urinary tract tumors, implicating this virus in neoplastic processes. BKV T antigen (TAg) is highly homologous to simian virus 40 TAg, particularly in regions required for mitogenic stimulation and binding to tumor suppressor proteins, The experiments presented in this report show that BKV TAg can bind the tumor suppressor protein p53. BKV TAg also has the ability to bind to members of the retinoblastoma (pRb) family of tumor suppressor proteins both in vivo and in vitro. However, these interactions are detected only when large amounts of total protein are used, because the levels of BKV TAg normally produced from viral promoter-enhancer elements are too low to bind a significant amount of the pRb family proteins in the cell. The low levels of BKV TAg produced by the viral promoter elements are sufficient to affect the levels and the phosphorylation patterns of these proteins and to induce serum-independent growth in these cells. Additional events, however, are required for full transformation. These data further support the notion that BKV TAg can affect cellular growth control mechanisms and may in fact be involved in neoplastic processes.
AbstractList	BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV DNA has also been found in human brain, pancreatic islet, and urinary tract tumors, implicating this virus in neoplastic processes. BKV T antigen (TAg) is highly homologous to simian virus 40 TAg, particularly in regions required for mitogenic stimulation and binding to tumor suppressor proteins, The experiments presented in this report show that BKV TAg can bind the tumor suppressor protein p53. BKV TAg also has the ability to bind to members of the retinoblastoma (pRb) family of tumor suppressor proteins both in vivo and in vitro. However, these interactions are detected only when large amounts of total protein are used, because the levels of BKV TAg normally produced from viral promoter-enhancer elements are too low to bind a significant amount of the pRb family proteins in the cell. The low levels of BKV TAg produced by the viral promoter elements are sufficient to affect the levels and the phosphorylation patterns of these proteins and to induce serum-independent growth in these cells. Additional events, however, are required for full transformation. These data further support the notion that BKV TAg can affect cellular growth control mechanisms and may in fact be involved in neoplastic processes. BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV DNA has also been found in human brain, pancreatic islet, and urinary tract tumors, implicating this virus in neoplastic processes. BKV T antigen (TAg) is highly homologous to simian virus 40 TAg, particularly in regions required for mitogenic stimulation and binding to tumor suppressor proteins, The experiments presented in this report show that BKV TAg can bind the tumor suppressor protein p53. BKV TAg also has the ability to bind to members of the retinoblastoma (pRb) family of tumor suppressor proteins both in vivo and in vitro. However, these interactions are detected only when large amounts of total protein are used, because the levels of BKV TAg normally produced from viral promoter-enhancer elements are too low to bind a significant amount of the pRb family proteins in the cell. The low levels of BKV TAg produced by the viral promoter elements are sufficient to affect the levels and the phosphorylation patterns of these proteins and to induce serum-independent growth in these cells. Additional events, however, are required for full transformation. These data further support the notion that BKV TAg can affect cellular growth control mechanisms and may in fact be involved in neoplastic processes.BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV DNA has also been found in human brain, pancreatic islet, and urinary tract tumors, implicating this virus in neoplastic processes. BKV T antigen (TAg) is highly homologous to simian virus 40 TAg, particularly in regions required for mitogenic stimulation and binding to tumor suppressor proteins, The experiments presented in this report show that BKV TAg can bind the tumor suppressor protein p53. BKV TAg also has the ability to bind to members of the retinoblastoma (pRb) family of tumor suppressor proteins both in vivo and in vitro. However, these interactions are detected only when large amounts of total protein are used, because the levels of BKV TAg normally produced from viral promoter-enhancer elements are too low to bind a significant amount of the pRb family proteins in the cell. The low levels of BKV TAg produced by the viral promoter elements are sufficient to affect the levels and the phosphorylation patterns of these proteins and to induce serum-independent growth in these cells. Additional events, however, are required for full transformation. These data further support the notion that BKV TAg can affect cellular growth control mechanisms and may in fact be involved in neoplastic processes.
Author	Imperiale, M J Christensen, J B Harris, K F
Author_xml	– sequence: 1 givenname: K F surname: Harris fullname: Harris, K F organization: Graduate Program in Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor 48109-0620, USA – sequence: 2 givenname: J B surname: Christensen fullname: Christensen, J B – sequence: 3 givenname: M J surname: Imperiale fullname: Imperiale, M J
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/8642665$$D View this record in MEDLINE/PubMed
BookMark	eNotULtOwzAU9VBUSuETEJ7YEhzbsR02qHiJSixFYouc9KZ1ldjBdlr1E_hrguh0j3TPS-cCTayzgNBNRtIso-putzepJClPKZMqoUyJNCsKMUEzQihNcqa-ztFFCDtCMs4Fn6KpEpwKkc_Qz-M73hs_BNxqvwG8wtpGswF7j42N4HUdjbMBH0zc4rgF7CEa66pWh-g6jRvdmfaIXYPj0DmPw9D3HkIYYe9dBDNqtV1jaBqoY8DO4hradhjT8Ma7w-haOxu9ay_RWaPbAFenO0efz0-rxWuy_Hh5Wzwsk5rlVCT1WrKGM8iZkHXOCRE8I7nQhQKRiUo0Kodajs9MAKkYpyCp4kQSynilIadzdPvvO_b7HiDEsjPhr5O24IZQSjlupwo2Eq9PxKHqYF323nTaH8vTdvQXVCx0kA
CitedBy_id	crossref_primary_10_1128_JVI_77_6_3586_3594_2003 crossref_primary_10_1016_j_virusres_2023_199220 crossref_primary_10_3389_fcimb_2023_1263983 crossref_primary_10_1038_sj_onc_1207920 crossref_primary_10_1128_JVI_02097_06 crossref_primary_10_1128_JVI_00256_06 crossref_primary_10_1128_JVI_00385_13 crossref_primary_10_1186_s12985_023_02128_6 crossref_primary_10_1128_JVI_02456_09 crossref_primary_10_1128_MCB_17_9_4979 crossref_primary_10_1128_CMR_00074_16 crossref_primary_10_1016_j_intimp_2020_107331 crossref_primary_10_1038_sj_onc_1209621 crossref_primary_10_1016_j_micpath_2023_106292 crossref_primary_10_1038_sj_onc_1206550 crossref_primary_10_1128_JVI_02461_07 crossref_primary_10_1038_sj_onc_1209266 crossref_primary_10_1146_annurev_micro_092611_150154 crossref_primary_10_1177_039463200702000223 crossref_primary_10_3390_v9110327 crossref_primary_10_1111_j_1600_6143_2008_02269_x crossref_primary_10_1128_JVI_02916_13 crossref_primary_10_1002_jcp_20300 crossref_primary_10_1128_JVI_75_21_10446_10454_2001 crossref_primary_10_1111_j_1600_6143_2007_01817_x crossref_primary_10_1006_viro_2000_0451 crossref_primary_10_1128_MCB_18_3_1746 crossref_primary_10_1002_mbo3_70061 crossref_primary_10_1016_j_yexcr_2004_03_045 crossref_primary_10_1016_j_virol_2005_01_048 crossref_primary_10_1016_j_tvr_2024_200306 crossref_primary_10_2217_fvl_2017_0013 crossref_primary_10_1038_sj_onc_1204916 crossref_primary_10_1128_JVI_00595_19 crossref_primary_10_1371_journal_pone_0282534 crossref_primary_10_1016_j_virol_2009_10_047 crossref_primary_10_1128_JVI_01918_09 crossref_primary_10_3390_life13071526 crossref_primary_10_1016_j_virol_2012_07_013 crossref_primary_10_1128_MMBR_66_2_179_202_2002 crossref_primary_10_1016_j_micinf_2012_02_002 crossref_primary_10_1038_sj_onc_1209618 crossref_primary_10_1128_MCB_17_8_4761 crossref_primary_10_3390_v15112235 crossref_primary_10_3390_ijms20163914 crossref_primary_10_1155_2021_9176993 crossref_primary_10_1186_1750_9378_9_41 crossref_primary_10_3390_v17060835 crossref_primary_10_1074_jbc_M114_594895 crossref_primary_10_1128_JVI_00300_09 crossref_primary_10_1016_j_virol_2004_03_025 crossref_primary_10_1128_JVI_80_4_1965_1971_2006 crossref_primary_10_1006_viro_1999_0092 crossref_primary_10_1074_jbc_M109_055491
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1128/jvi.70.4.2378-2386.1996
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Biology
ExternalDocumentID	8642665
Genre	Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article
GrantInformation_xml	– fundername: NIGMS NIH HHS grantid: 5-T32-GM07315
GroupedDBID	--- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAYJJ ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A NPM O9- OHT OK1 P2P PKN RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM 7X8 AAFWJ AAGFI
ID	FETCH-LOGICAL-c3526-cd73f43e5367c5400641056a98e616b6f85ec736716e0b342e7284070234bae52
IEDL.DBID	7X8
ISSN	0022-538X
IngestDate	Fri Sep 05 10:13:42 EDT 2025 Wed Feb 19 01:27:13 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c3526-cd73f43e5367c5400641056a98e616b6f85ec736716e0b342e7284070234bae52
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://jvi.asm.org/content/jvi/70/4/2378.full.pdf
PMID	8642665
PQID	77996893
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_77996893 pubmed_primary_8642665
PublicationCentury	1900
PublicationDate	19960401
PublicationDateYYYYMMDD	1996-04-01
PublicationDate_xml	– month: 4 year: 1996 text: 19960401 day: 1
PublicationDecade	1990
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of virology
PublicationTitleAlternate	J Virol
PublicationYear	1996
References	8343202 - Cell. 1993 May 7;73(3):487-97 2154613 - J Virol. 1990 Mar;64(3):1353-6 8387205 - Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92 1828392 - Cell. 1991 Jun 14;65(6):1053-61 2846874 - J Virol. 1988 Dec;62(12):4613-21 1828393 - Cell. 1991 Jun 14;65(6):1063-72 2154603 - J Virol. 1990 Mar;64(3):1182-91 1388095 - Cell. 1992 Sep 18;70(6):993-1006 8402885 - Cell. 1993 Sep 24;74(6):957-67 2521957 - Science. 1989 Feb 17;243(4893):937-40 7651744 - Oncogene. 1995 Aug 17;11(4):801-8 8253384 - Genes Dev. 1993 Dec;7(12A):2378-91 2839300 - Cell. 1988 Jul 15;54(2):275-83 2535898 - Virology. 1989 Jan;168(1):13-21 2539697 - Virology. 1989 Apr;169(2):385-96 2536108 - J Virol. 1989 Feb;63(2):863-72 1318392 - J Virol. 1992 Jul;66(7):3979-85 2968523 - Nature. 1988 Jul 14;334(6178):168-70 778304 - J Infect Dis. 1976 Jun;133(6):686-90 3023923 - Mol Cell Biol. 1986 Jun;6(6):2233-40 219257 - J Virol. 1979 Feb;29(2):763-9 3041175 - Mol Biol Med. 1987 Apr;4(2):63-80 1531040 - Cell. 1992 Jan 10;68(1):157-66 2153075 - EMBO J. 1990 Jan;9(1):153-60 8319904 - Genes Dev. 1993 Jul;7(7A):1111-25 1323237 - Annu Rev Biochem. 1992;61:55-85 5432063 - Nature. 1970 Aug 15;227(5259):680-5 8449399 - Genes Dev. 1993 Mar;7(3):331-42 7954824 - Cell. 1994 Nov 18;79(4):573-82 7797074 - Genes Dev. 1995 Jun 1;9(11):1340-53 221672 - J Virol. 1979 Mar;29(3):1177-85 6251275 - J Virol. 1980 Jul;35(1):265-9 2968522 - Nature. 1988 Jul 14;334(6178):124-9 1614522 - Nature. 1992 Jul 2;358(6381):15-6 8391217 - Am J Pathol. 1993 Jul;143(1):29-39 163364 - J Virol. 1975 Feb;15(2):420-2 6086957 - J Virol. 1984 Aug;51(2):458-69 1833063 - Cell. 1991 Sep 20;66(6):1155-64 8479523 - Nature. 1993 Apr 29;362(6423):849-52 1655277 - Cell. 1991 Oct 18;67(2):293-302 8525628 - Virology. 1995 Dec 1;214(1):273-9 8479522 - Nature. 1993 Apr 29;362(6423):847-9 7736585 - Cell. 1995 May 5;81(3):323-30 2910497 - Cell. 1989 Jan 13;56(1):57-65 3014334 - N Engl J Med. 1986 Jul 24;315(4):230-4 4214938 - J Natl Cancer Inst. 1974 Nov;53(5):1205-7 3025111 - Int J Cancer. 1987 Jan 15;39(1):60-7 1411535 - Science. 1992 Oct 16;258(5081):424-9 6169844 - J Virol. 1981 Sep;39(3):861-9 6313219 - Cell. 1983 Nov;35(1):127-36 4353360 - Science. 1973 Aug 17;181(4100):674-6 2526683 - Cell. 1989 Jul 28;58(2):257-67 1825028 - Cell. 1991 Feb 8;64(3):521-32 8413249 - Mol Cell Biol. 1993 Oct;13(10):6501-8 1829647 - Cell. 1991 Jun 28;65(7):1243-53 6257931 - J Virol. 1980 Dec;36(3):878-82 7784051 - Oncogene. 1995 Jun 1;10(11):2067-78 1531329 - Genes Dev. 1992 Feb;6(2):177-85 8377827 - Nature. 1993 Sep 23;365(6444):349-52 6260373 - Cell. 1981 Jan;23(1):175-82 2957849 - Virology. 1987 Sep;160(1):292-6 1531876 - Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1795-8 1532457 - Science. 1992 Jan 3;255(5040):85-7 8394683 - Annu Rev Biochem. 1993;62:623-51 2991597 - J Virol. 1985 Sep;55(3):823-5 8490963 - Cell. 1993 May 7;73(3):499-511 229976 - Cell. 1979 Dec;18(4):963-77 8253383 - Genes Dev. 1993 Dec;7(12A):2366-77 7705662 - Genes Dev. 1995 Apr 1;9(7):869-81 3009880 - J Virol. 1986 May;58(2):680-3 7794807 - Cell Growth Differ. 1995 Apr;6(4):395-407 2430282 - Proc Natl Acad Sci U S A. 1986 Nov;83(21):8288-92 4104714 - Lancet. 1971 Jun 19;1(7712):1253-7 8253385 - Genes Dev. 1993 Dec;7(12A):2392-404 20791873 - Br Med J. 1973 Jan 13;1(5845):77-8 8458319 - EMBO J. 1993 Mar;12(3):1013-20 8396798 - Virology. 1993 Oct;196(2):458-74 8259683 - Virology. 1994 Jan;198(1):59-70 2546678 - Cell. 1989 Jul 28;58(2):249-55 6286831 - J Mol Appl Genet. 1982;1(4):327-41 1316611 - Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 2167547 - Virology. 1990 Sep;178(1):15-34 1933891 - Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 205675 - J Virol. 1978 Mar;25(3):860-70
References_xml	– reference: 6313219 - Cell. 1983 Nov;35(1):127-36 – reference: 8396798 - Virology. 1993 Oct;196(2):458-74 – reference: 1531876 - Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1795-8 – reference: 8479522 - Nature. 1993 Apr 29;362(6423):847-9 – reference: 7794807 - Cell Growth Differ. 1995 Apr;6(4):395-407 – reference: 2521957 - Science. 1989 Feb 17;243(4893):937-40 – reference: 1933891 - Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 – reference: 8391217 - Am J Pathol. 1993 Jul;143(1):29-39 – reference: 8449399 - Genes Dev. 1993 Mar;7(3):331-42 – reference: 8319904 - Genes Dev. 1993 Jul;7(7A):1111-25 – reference: 7651744 - Oncogene. 1995 Aug 17;11(4):801-8 – reference: 6260373 - Cell. 1981 Jan;23(1):175-82 – reference: 3009880 - J Virol. 1986 May;58(2):680-3 – reference: 7954824 - Cell. 1994 Nov 18;79(4):573-82 – reference: 3041175 - Mol Biol Med. 1987 Apr;4(2):63-80 – reference: 5432063 - Nature. 1970 Aug 15;227(5259):680-5 – reference: 6257931 - J Virol. 1980 Dec;36(3):878-82 – reference: 8394683 - Annu Rev Biochem. 1993;62:623-51 – reference: 163364 - J Virol. 1975 Feb;15(2):420-2 – reference: 219257 - J Virol. 1979 Feb;29(2):763-9 – reference: 7784051 - Oncogene. 1995 Jun 1;10(11):2067-78 – reference: 221672 - J Virol. 1979 Mar;29(3):1177-85 – reference: 1318392 - J Virol. 1992 Jul;66(7):3979-85 – reference: 1828393 - Cell. 1991 Jun 14;65(6):1063-72 – reference: 8253384 - Genes Dev. 1993 Dec;7(12A):2378-91 – reference: 2167547 - Virology. 1990 Sep;178(1):15-34 – reference: 8458319 - EMBO J. 1993 Mar;12(3):1013-20 – reference: 1316611 - Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 – reference: 8377827 - Nature. 1993 Sep 23;365(6444):349-52 – reference: 2154613 - J Virol. 1990 Mar;64(3):1353-6 – reference: 2539697 - Virology. 1989 Apr;169(2):385-96 – reference: 2991597 - J Virol. 1985 Sep;55(3):823-5 – reference: 4353360 - Science. 1973 Aug 17;181(4100):674-6 – reference: 1388095 - Cell. 1992 Sep 18;70(6):993-1006 – reference: 1411535 - Science. 1992 Oct 16;258(5081):424-9 – reference: 4214938 - J Natl Cancer Inst. 1974 Nov;53(5):1205-7 – reference: 229976 - Cell. 1979 Dec;18(4):963-77 – reference: 2526683 - Cell. 1989 Jul 28;58(2):257-67 – reference: 2839300 - Cell. 1988 Jul 15;54(2):275-83 – reference: 2535898 - Virology. 1989 Jan;168(1):13-21 – reference: 1531329 - Genes Dev. 1992 Feb;6(2):177-85 – reference: 2153075 - EMBO J. 1990 Jan;9(1):153-60 – reference: 7736585 - Cell. 1995 May 5;81(3):323-30 – reference: 20791873 - Br Med J. 1973 Jan 13;1(5845):77-8 – reference: 1531040 - Cell. 1992 Jan 10;68(1):157-66 – reference: 8402885 - Cell. 1993 Sep 24;74(6):957-67 – reference: 2968523 - Nature. 1988 Jul 14;334(6178):168-70 – reference: 8490963 - Cell. 1993 May 7;73(3):499-511 – reference: 205675 - J Virol. 1978 Mar;25(3):860-70 – reference: 8525628 - Virology. 1995 Dec 1;214(1):273-9 – reference: 778304 - J Infect Dis. 1976 Jun;133(6):686-90 – reference: 2846874 - J Virol. 1988 Dec;62(12):4613-21 – reference: 3025111 - Int J Cancer. 1987 Jan 15;39(1):60-7 – reference: 2546678 - Cell. 1989 Jul 28;58(2):249-55 – reference: 8253383 - Genes Dev. 1993 Dec;7(12A):2366-77 – reference: 7797074 - Genes Dev. 1995 Jun 1;9(11):1340-53 – reference: 2957849 - Virology. 1987 Sep;160(1):292-6 – reference: 1825028 - Cell. 1991 Feb 8;64(3):521-32 – reference: 1323237 - Annu Rev Biochem. 1992;61:55-85 – reference: 8413249 - Mol Cell Biol. 1993 Oct;13(10):6501-8 – reference: 6169844 - J Virol. 1981 Sep;39(3):861-9 – reference: 2154603 - J Virol. 1990 Mar;64(3):1182-91 – reference: 8259683 - Virology. 1994 Jan;198(1):59-70 – reference: 3023923 - Mol Cell Biol. 1986 Jun;6(6):2233-40 – reference: 2968522 - Nature. 1988 Jul 14;334(6178):124-9 – reference: 6286831 - J Mol Appl Genet. 1982;1(4):327-41 – reference: 1828392 - Cell. 1991 Jun 14;65(6):1053-61 – reference: 2910497 - Cell. 1989 Jan 13;56(1):57-65 – reference: 8479523 - Nature. 1993 Apr 29;362(6423):849-52 – reference: 1614522 - Nature. 1992 Jul 2;358(6381):15-6 – reference: 6086957 - J Virol. 1984 Aug;51(2):458-69 – reference: 2430282 - Proc Natl Acad Sci U S A. 1986 Nov;83(21):8288-92 – reference: 3014334 - N Engl J Med. 1986 Jul 24;315(4):230-4 – reference: 1532457 - Science. 1992 Jan 3;255(5040):85-7 – reference: 7705662 - Genes Dev. 1995 Apr 1;9(7):869-81 – reference: 8387205 - Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92 – reference: 6251275 - J Virol. 1980 Jul;35(1):265-9 – reference: 1655277 - Cell. 1991 Oct 18;67(2):293-302 – reference: 1833063 - Cell. 1991 Sep 20;66(6):1155-64 – reference: 4104714 - Lancet. 1971 Jun 19;1(7712):1253-7 – reference: 1829647 - Cell. 1991 Jun 28;65(7):1243-53 – reference: 8343202 - Cell. 1993 May 7;73(3):487-97 – reference: 8253385 - Genes Dev. 1993 Dec;7(12A):2392-404 – reference: 2536108 - J Virol. 1989 Feb;63(2):863-72
SSID	ssj0014464
Score	1.8525443
Snippet	BK virus (BKV) is a polyomavirus which infects a large percentage of the human population. It is a potent transforming agent and is tumorigenic in rodents. BKV...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	2378
SubjectTerms	Animals Antigens, Polyomavirus Transforming - metabolism Antigens, Polyomavirus Transforming - physiology BK Virus - immunology BK Virus - physiology Cell Division Cell Line Cell Transformation, Viral - physiology Cercopithecus aethiops Humans Nuclear Proteins - metabolism Phosphoproteins - metabolism Protein Binding Proteins Retinoblastoma Protein - metabolism Retinoblastoma-Like Protein p107 Retinoblastoma-Like Protein p130 Tumor Suppressor Protein p53 - metabolism
Title	BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control
URI	https://www.ncbi.nlm.nih.gov/pubmed/8642665 https://www.proquest.com/docview/77996893
Volume	70
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7rC7z4Ft_OwWt3u22atCKIiovPxYNKb0uaprKg7dpuBX-C_9qZPvAkHryUQkkp6WTmm-Sbbxg7CqRSwna0xaUtLe5ExvKj2LNijblzogKhKp3u5zs5HPphGDx02ElbC0O0ytYnVo46zjTtkfekRGSOwfV08m5Rzyg6W20aaMywOReBDNm0DH_OEDDR4a1WOC7rsGF3oUPu3Txfd6Xd5V3HxSQKo5agqj3xO8qsos1g-X_fucKWGpQJZ7VZrLKOSdfYQt138nOdfZ3fwsc4Lwt4JSI4PALOL8lyHgPJR-R1sUMBtEkLiBCBSh3TLEKkPc3eFNS7IpAlMC3fshyKclLxafG20n0Y41iVxtCQRSBLgQ4IiPEKL5j341sbivwGexpcPl5cWU1PBkuTkr6lY-km3DWeK6RGtIeIBhGaUIFvRF9EIvE9oyU-7AtjRy53jMQAiH7FcXmkjOdsstk0S80WAym0E8SY7mmjeODEvmcbE0QIQXyupBdvs8N2hkdo8_SdKjVZWYzaOd5mm_VPGk1qaY6RLwhxeDt_Dt1lizX_mjg4e2wuwcVu9tm8_piOi_ygsiS8Dh_uvwGp9dQF
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BK+virus+large+T+antigen%3A+interactions+with+the+retinoblastoma+family+of+tumor+suppressor+proteins+and+effects+on+cellular+growth+control&rft.jtitle=Journal+of+virology&rft.au=Harris%2C+K+F&rft.au=Christensen%2C+J+B&rft.au=Imperiale%2C+M+J&rft.date=1996-04-01&rft.issn=0022-538X&rft.volume=70&rft.issue=4&rft.spage=2378&rft_id=info:doi/10.1128%2FJVI.70.4.2378-2386.1996&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon